<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="62510">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02292147</url>
  </required_header>
  <id_info>
    <org_study_id>P111012</org_study_id>
    <nct_id>NCT02292147</nct_id>
  </id_info>
  <brief_title>Functional Outcome After Cardiac Arrest</brief_title>
  <acronym>HANOX</acronym>
  <official_title>Functional Outcome After Cardiac Arrest; Prediction and Prognosis Factors for Patients Awake Within the First 15 Days</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Descriptive and prognosis study of the functional outcome after cardiac arrest for the
      patients awake within the first 15 days.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Functional outcome after cerebral anoxia due to cardiac arrest is poorly documented..
      Survival after out of hospital cardiac arrest has improved and long term follow up of the
      patients is not routinely effective. Patients showing sign of awakening very early are
      considered in a good outcome group. Nevertheless they can experience some restriction and
      difficulties when they try to return to their premorbid level of functioning.

      We aim to study their long term functional outcome and their level of anxiety, depression,
      quality of life and caregiver burden as well as their general cognitive functioning.
      Prognosis factors will be studied in the acute phase.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">November 2017</completion_date>
  <primary_completion_date type="Anticipated">November 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Glasgow outcome Scale Extended score</measure>
    <time_frame>18 months</time_frame>
    <description>Functional outcome at 18 months</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Out of Hospital Cardiac Arrest</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients presenting an Out of hospital cardiac arrest
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria :

          -  age 18 to 85

          -  Out of hospital cardiac arrest ; cardiac arrest in the ER is eligible

          -  Glasgow Coma Score ≥ 12 within 15 days after onset - Living in the parisian area

        Exclusion criteria :

          -  no social security

          -  Neurological condition (multiple sclerosis, parkinson disease, AMS, stroke) priori to
             the cardiac arrest

          -  Psychiatric condition (schizophrenia, severe bipolar syndrome, long term neuroleptic
             medication, autistic spectrum disorders

          -  Deafness and blindness

          -  Neoplasia

          -  Premorbid limitation of autonomy.

          -  Difficulties in speaking and writing the French language
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anne Peskine, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anne Peskine, MD</last_name>
    <phone>+33(0) 1 42 16 11 49</phone>
    <email>anne.peskine@psl.aphp.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Charles-Edouard Luyt, MD, PhD</last_name>
    <phone>+33(0) 42 16 38 24</phone>
    <email>charles-edouard.luyt@psl.aphp.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Pitié salpetriere Hospital</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne Peskine, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <lastchanged_date>July 19, 2016</lastchanged_date>
  <firstreceived_date>November 12, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cerebral anoxia</keyword>
  <keyword>Functional outcome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Arrest</mesh_term>
    <mesh_term>Out-of-Hospital Cardiac Arrest</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
